C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
01/2010
01/05/2010	US7642272 Cannabinoid receptor ligands
01/05/2010	US7642267 Benzimidazole and pyridylimidazole derivatives
01/05/2010	US7642265 Benzimidazoles and analogs thereof as antivirals
01/05/2010	US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia
01/05/2010	CA2545999C 1,2-di(cyclic)substituted benzene compounds
01/05/2010	CA2390100C Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
01/05/2010	CA2383769C Indole derivatives
01/05/2010	CA2185397C Arylalkyl-diazinones
12/2009
12/31/2009	US20090326233 4-phenylpiperidine compounds
12/31/2009	US20090326220 Tetrazole-Substituted Arylamides as P2X3 and P2X2/3 Antagonists
12/31/2009	US20090325990 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
12/31/2009	US20090325966 s-Triazine compounds, pharmaceutical compositions and method of using the same
12/31/2009	US20090325955 Gyrase inhibitors and uses thereof
12/31/2009	US20090325935 Gyrase inhibitors and uses thereof
12/31/2009	US20090325927 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
12/30/2009	WO2009158473A1 5- and 6-membered heterocyclic compounds
12/30/2009	WO2009158426A1 6-substituted phenoxychroman carboxylic acid derivatives
12/30/2009	WO2009158393A1 1, 2 disubstituted heterocyclic compounds
12/30/2009	WO2009158381A1 Novel psymberin derivatives, compositions, and their use as antineoplastic agents
12/30/2009	WO2009157860A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009	WO2009157399A1 Sulfonamide compound or salt thereof
12/30/2009	WO2009156099A1 6-substituted isoquinolines and isoquinolinones
12/30/2009	WO2009156072A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
12/30/2009	EP2138491A1 Optically active epoxy compound
12/30/2009	EP2138482A1 Bicyclic heterocyclic compound
12/30/2009	EP2138179A1 Use of cytidine derivatives for the treatment of leukaemia
12/30/2009	EP2138177A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
12/30/2009	EP2137166A1 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/30/2009	EP2137154A2 Pyridine compounds for liquid-crystalline mixtures
12/30/2009	EP2057148B1 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents
12/30/2009	EP1620395B1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders
12/30/2009	EP1608632B1 Quinazolines useful as modulators of ion channels
12/30/2009	EP1501812B1 Pna monomer and precursor
12/30/2009	EP1409482B1 Dye-sulfenates for dual phototherapy
12/30/2009	CN101613344A Fluorescent probe for selectively detecting zinc ions in cells, synthesizing method thereof and application thereof
12/30/2009	CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009	CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
12/30/2009	CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009	CN100575342C Substituted spirocyclic ketoenols
12/30/2009	CA2729275A1 5- and 6-membered heterocyclic compounds
12/30/2009	CA2729259A1 1,2-disubstituted heterocyclic compounds
12/30/2009	CA2729217A1 6-substituted phenoxychroman carboxylic acid derivatives
12/30/2009	CA2729052A1 Salts of methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
12/30/2009	CA2729048A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
12/30/2009	CA2728511A1 Sulfonamide compounds or salts thereof
12/30/2009	CA2728128A1 6-substituted isoquinolines and isoquinolinones
12/30/2009	CA2727925A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009	CA2727573A1 Diaryl compounds and uses thereof
12/29/2009	US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638540 Benzofuran compound and medicinal composition containing the same
12/29/2009	US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors
12/29/2009	US7638535 (3S)-trans)-8-methyl-3,4-dihydro-2H-benzo[b][1,4]dioxepine-6-carboxylic acid [3-hydroxy-1-(3-methoxy-propyl)-piperidin-4-ylmethyl]-amide; hypermotility, irritable bowel syndrome, constipation or diarrhea predominant IDS, pain and non-pain predominant IBS and bowel hypersensitivity
12/29/2009	US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009	US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation
12/29/2009	CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/29/2009	CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/29/2009	CA2428511C Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
12/29/2009	CA2424522C Substituted benzene derivatives or salts thereof
12/29/2009	CA2410311C Barbituric acid analogs as therapeutic agents
12/29/2009	CA2408914C Novel triazolo pyrimidine compounds
12/29/2009	CA2393183C Process for the preparation of 5-(1-piperazinyl)benzofuran-2-carboxamide by transition metal-catalysed amination
12/29/2009	CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009	CA2338543C Method of direct identification of compound efficacy at a g protein-coupled orphan receptor
12/29/2009	CA2321792C Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation
12/29/2009	CA2287214C Substituted benzopyran derivatives for the treatment of inflammation
12/29/2009	CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules
12/24/2009	US20090318687 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
12/24/2009	US20090318504 Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
12/24/2009	US20090318501 Piperidine derivatives as renin inhibitors
12/24/2009	US20090318479 Substituted ring fused azines and their use in cancer therapy
12/24/2009	US20090318472 Aminopyrazine derivatives and compositions
12/24/2009	US20090318447 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
12/24/2009	US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
12/24/2009	US20090318439 5-furopyridinone substituted indazoles
12/24/2009	US20090318438 Heterocyclic compounds and their use as anticancer agents
12/24/2009	US20090318373 Receptor-type kinase modulators and methods of use
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009154780A1 S1p1 receptor agonists and use thereof
12/23/2009	WO2009153589A1 Pyridine compounds
12/23/2009	WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153178A2 Aryl ketone as mri
12/23/2009	WO2008152331A9 Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
12/23/2009	EP2135868A1 Trans-9, 10-dehydroepothilone c and d, analogs thereof and methods of making the same
12/23/2009	EP2135867A1 Trans-9, 10-dehydroepothilone C and trans-9, 10-dehydroepothilone D, analogs thereof and methods of making the same
12/23/2009	EP2135866A1 New dihydropyrimidine compounds and their uses in manufactures of pharmaceutical medicaments for treatment and prevention against virosis
12/23/2009	EP2135620A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
12/23/2009	EP2134708A1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
12/23/2009	EP2134693A2 Metalloprotease inhibitors containing a heterocyclic moiety
12/23/2009	EP2134690A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
12/23/2009	EP2134687A1 Piperazine and piperidine mglur5 potentiators
12/23/2009	EP1720859B1 Chemokine receptor antagonists
12/23/2009	EP1709037B1 Hiv protease inhibiting sulfonamides
12/23/2009	EP1562941B1 Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same
12/23/2009	EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors
12/23/2009	CN101611018A Heterocyclyc sulfonamides having Edg-I antagonistic activity
12/23/2009	CN101611014A Acylaminopyrazoles as FGFR inhibitors

1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 694